The spots are not dangerous and the product can still be used. BioGaia tablets contains ascorbic acid, which is an antioxidant that contributes to the stability of the tablets. Over time the ascorbic acid oxidizes and the color becomes darker. This darkening is seen as small “spots” on the tablet.
Products that contain several strains do not necessarily have better effect than single strain products. Most important is that the strain or strains have shown clinical efficacy in clinical studies.
Lactobacillus reuteri is a probiotic strain that has co-evolved with humans since the beginning of time, and because of that it is adapted to its host. L. reuteri is among the first bacterial species to become naturally established in the normal microbiota of the newborn.
BioGaia’s probiotic products with L. reuteri are among the most scientifically well-documented probiotics in the world with regard to both efficacy and safety. To date the efficacy and safety of BioGaia’s different strains of L. reuteri have been documented in 184 clinical studies in 15,500 people of all ages. Results have been published in 159 papers in scientific journals (February 2018).
Read more about Lactobacillus reuteri.
Exposure to high temperatures and/or high humidity accelerates the degradation of the probiotic bacteria. If exposure is too long it will result in a shorter shelf-life of the product, but the product is still safe to use.
Probiotics are good bacteria that are found in food or supplements. The definition is ”Live microorganisms that, when administered in adequate amounts, confer a health benefit on the host.” (WHO/FAO, 2002). Important criteria for qualifying as a true probiotic is that health benefits should be proven in clinical trials. Furthermore, a probiotic product must contain the same bacterial strain(s) and the same dose that was used in the clinical trials.
Read more about probiotics.
BioGaia products are free from allergens like milk, gluten, egg, peanuts, tree nuts, fish, shellfish, soy.
Our products are sold through around 80 local distribution partners in 100 countries. Most of our products are sold through the major pharmacy chains. For further information regarding buying locations we recommend you to contact the company with distribution rights in your country. Please follow this link to go to your country.
Open study to investigate if the eradication rate of H. pylori in adults is improved by L. reuteri DSM 17938, as an adjunct during 10-day eradication therapy and for 10 days thereafter. Forty-five (45) patients were included.
The rate of eradication was 93.3% (42/45). In 2/4 (50%) previously treated for H. pylori the infection was also eradicated.
Side effects were reported in 8 subjects: mild diarrhoea for a few days (n=5), and abdominal discomfort (n=3).
Proton pump inhibitor-tetracycline-metronidazole-L. reuteri therapy provided high eradication rates with few side effects, and excellent compliance.
BioGaia Gastrus is a food supplement containing the patented lactic acid bacterium Lactobacillus reuteri Gastrus®/™ (L. reuteri DSM 17938 and L. reuteri ATCC PTA 6475). Because both strains in L. reuteri Gastrus naturally colonize humans they have a strong adaptation to persist and interact with humans. BioGaia Gastrus has been tested in clinical trials and proven effective and safe.